NYSE:PBH Prestige Consumer Healthcare (PBH) Stock Forecast, Price & News $56.70 -0.53 (-0.93%) (As of 06/1/2023 ET) Add Compare Share Share Today's Range$56.54▼$57.3950-Day Range$56.70▼$63.7652-Week Range$48.51▼$67.45Volume216,395 shsAverage Volume252,144 shsMarket Capitalization$2.82 billionP/E RatioN/ADividend YieldN/APrice Target$79.25 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Prestige Consumer Healthcare MarketRank™ ForecastAnalyst RatingModerate Buy2.60 Rating ScoreUpside/Downside39.8% Upside$79.25 Price TargetShort InterestBearish2.44% of Float Sold ShortDividend StrengthN/ASustainability-2.35Upright™ Environmental ScoreNews Sentiment1.01Based on 6 Articles This WeekInsider TradingN/AProj. Earnings Growth6.98%From $4.30 to $4.60 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.11 out of 5 starsConsumer Discretionary Sector337th out of 546 stocksPharmaceutical Preparations Industry473rd out of 978 stocks 3.3 Analyst's Opinion Consensus RatingPrestige Consumer Healthcare has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $79.25, Prestige Consumer Healthcare has a forecasted upside of 39.8% from its current price of $56.70.Amount of Analyst CoveragePrestige Consumer Healthcare has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.44% of the float of Prestige Consumer Healthcare has been sold short.Short Interest Ratio / Days to CoverPrestige Consumer Healthcare has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in Prestige Consumer Healthcare has recently increased by 5.26%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldPrestige Consumer Healthcare does not currently pay a dividend.Dividend GrowthPrestige Consumer Healthcare does not have a long track record of dividend growth. Previous Next 3.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScorePrestige Consumer Healthcare has received a 42.29% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Dental floss", "Topical capsaicin", "Mouthwash", "Lice shampoo", "Montelukast", and "Yeast infection medicine" products. See details.Environmental SustainabilityThe Environmental Impact score for Prestige Consumer Healthcare is -2.35. Previous Next 2.8 News and Social Media Coverage News SentimentPrestige Consumer Healthcare has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Consumer Discretionary companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Prestige Consumer Healthcare this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 1 people have added Prestige Consumer Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Prestige Consumer Healthcare insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.60% of the stock of Prestige Consumer Healthcare is held by insiders.Percentage Held by Institutions99.98% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Prestige Consumer Healthcare are expected to grow by 6.98% in the coming year, from $4.30 to $4.60 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Prestige Consumer Healthcare is -33.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Prestige Consumer Healthcare is -33.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioPrestige Consumer Healthcare has a PEG Ratio of 1.69. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrestige Consumer Healthcare has a P/B Ratio of 1.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Prestige Consumer Healthcare (NYSE:PBH) StockPrestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.Read More Receive PBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address PBH Stock News HeadlinesJune 1, 2023 | finance.yahoo.comPrestige Consumer Healthcare (NYSE:PBH) shareholders are still up 62% over 5 years despite pulling back 3.5% in the past weekMay 31, 2023 | finance.yahoo.comGoody’s® Introduces New “GET TO GOOD™” Marketing CampaignJune 2, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.May 23, 2023 | finance.yahoo.comDramamine® Eases Americans’ Travel Woes with ‘Ditch the Drama’ Sweepstakes Offering a Vacation to Anywhere in the WorldMay 14, 2023 | americanbankingnews.comBrokerages Set Prestige Consumer Healthcare Inc. (NYSE:PBH) PT at $79.25May 11, 2023 | americanbankingnews.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Expected to Earn Q1 2024 Earnings of $1.01 Per ShareMay 10, 2023 | americanbankingnews.comPrestige Consumer Healthcare Inc. (NYSE:PBH) to Post Q1 2024 Earnings of $1.00 Per Share, William Blair ForecastsMay 9, 2023 | msn.comDA Davidson Reiterates Prestige Consumer Healthcare (PBH) Neutral RecommendationJune 2, 2023 | UNKNOWN (Ad)Lithium Has Boomed And This American Stock Is Ready..Lithium Has Been On A Crazy Rally Over The Last 3 Year's And This Stock Could Be Next!May 5, 2023 | finance.yahoo.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 42% Below Their Intrinsic Value EstimateMay 4, 2023 | msn.comPrestige Consumer (PBH) Q4 Earnings Top Estimates, Revenues UpMay 4, 2023 | finance.yahoo.comPrestige Brands (PBH) Beats Q4 Earnings and Revenue EstimatesMay 4, 2023 | finance.yahoo.comPrestige Consumer Healthcare Inc. Reports Record Fiscal Year 2023May 3, 2023 | americanbankingnews.comPrestige Consumer Healthcare (PBH) Scheduled to Post Earnings on ThursdayApril 25, 2023 | msn.comJ&J's $40 Billion Spinoff Has One Rival. Who Will Rule Consumer Health.April 19, 2023 | americanbankingnews.comBrokerages Set Prestige Consumer Healthcare Inc. (NYSE:PBH) PT at $77.40April 18, 2023 | finance.yahoo.comPrestige Consumer Healthcare Inc. to Release Fiscal 2023 Fourth Quarter and Year-End Earnings ResultsApril 13, 2023 | seekingalpha.comContinuing To Avoid Prestige Consumer HealthcareMarch 25, 2023 | americanbankingnews.comBrokerages Set Prestige Consumer Healthcare Inc. (NYSE:PBH) Price Target at $77.40March 20, 2023 | finance.yahoo.comPrestige Consumer Healthcare Inc. (PBH)March 17, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Lifecore Biomedical (LFCR), Prestige Consumer Healthcare (PBH) and Quest Diagnostics (DGX)February 25, 2023 | finance.yahoo.comPrestige Consumer Healthcare Inc.'s (NYSE:PBH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?February 4, 2023 | yahoo.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2023 Earnings Call TranscriptFebruary 2, 2023 | finance.yahoo.comPrestige Consumer Healthcare Inc. Reports Third Quarter ResultsFebruary 2, 2023 | finance.yahoo.comPrestige Brands (PBH) Q3 Earnings and Revenues Surpass EstimatesJanuary 27, 2023 | nasdaq.comPrestige Consumer (PBH) to Post Q3 Earnings: Factors to ConsiderJanuary 19, 2023 | seekingalpha.comPrestige Consumer Healthcare: Taking My Winnings Off The TableSee More Headlines PBH Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PBH Company Calendar Last Earnings5/04/2023Today6/01/2023Next Earnings (Estimated)8/03/2023Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Pharmaceutical preparations Sub-IndustryPersonal Products SectorConsumer Discretionary Current SymbolNYSE:PBH CUSIP74112D10 CIK1295947 Webwww.prestigebrands.com Phone(914) 524-6800Fax302-674-5266Employees505Year FoundedN/APrice Target and Rating Average Stock Price Forecast$79.25 High Stock Price Forecast$104.00 Low Stock Price Forecast$71.00 Forecasted Upside/Downside+39.8%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.68) Trailing P/E RatioN/A Forward P/E Ratio13.19 P/E Growth1.69Net Income$-82,310,000.00 Net Margins-7.30% Pretax Margin-8.33% Return on Equity13.38% Return on Assets5.86% Debt Debt-to-Equity Ratio0.93 Current Ratio2.44 Quick Ratio1.43 Sales & Book Value Annual Sales$1.13 billion Price / Sales2.50 Cash Flow$4.90 per share Price / Cash Flow11.58 Book Value$29.12 per share Price / Book1.95Miscellaneous Outstanding Shares49,690,000Free Float48,898,000Market Cap$2.82 billion OptionableOptionable Beta0.56 Key ExecutivesRonald M. LombardiChairman, President & Chief Executive OfficerJeff ZerilloSenior Vice President-OperationsChristine SaccoChief Financial OfficerWilliam C. P'PoolSecretary, Senior Vice President & General CounselAdel MekhailExecutive Vice President-Marketing & SalesKey CompetitorsTravel + LeisureNYSE:TNLUnder ArmourNYSE:UASendas DistribuidoraNYSE:ASAISpectrum BrandsNYSE:SPBAcushnetNYSE:GOLFView All CompetitorsInstitutional OwnershipProShare Advisors LLCSold 636 shares on 5/26/2023Ownership: 0.015%Legato Capital Management LLCSold 3,346 shares on 5/25/2023Ownership: 0.043%Toroso Investments LLCBought 5,988 shares on 5/23/2023Ownership: 0.012%Ameriprise Financial Inc.Bought 2,330 shares on 5/22/2023Ownership: 0.930%Trivant Custom Portfolio Group LLCBought 1,115 shares on 5/19/2023Ownership: 0.002%View All Institutional Transactions PBH Stock - Frequently Asked Questions Should I buy or sell Prestige Consumer Healthcare stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PBH shares. View PBH analyst ratings or view top-rated stocks. What is Prestige Consumer Healthcare's stock price forecast for 2023? 5 brokers have issued twelve-month price objectives for Prestige Consumer Healthcare's shares. Their PBH share price forecasts range from $71.00 to $104.00. On average, they predict the company's share price to reach $79.25 in the next year. This suggests a possible upside of 39.8% from the stock's current price. View analysts price targets for PBH or view top-rated stocks among Wall Street analysts. How have PBH shares performed in 2023? Prestige Consumer Healthcare's stock was trading at $62.60 at the start of the year. Since then, PBH stock has decreased by 9.4% and is now trading at $56.70. View the best growth stocks for 2023 here. When is Prestige Consumer Healthcare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our PBH earnings forecast. How were Prestige Consumer Healthcare's earnings last quarter? Prestige Consumer Healthcare Inc. (NYSE:PBH) posted its quarterly earnings data on Thursday, May, 4th. The company reported $1.07 earnings per share for the quarter, beating analysts' consensus estimates of $1.04 by $0.03. The firm earned $285.90 million during the quarter, compared to analyst estimates of $280.58 million. Prestige Consumer Healthcare had a positive trailing twelve-month return on equity of 13.38% and a negative net margin of 7.30%. The firm's quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.91 earnings per share. What ETFs hold Prestige Consumer Healthcare's stock? ETFs with the largest weight of Prestige Consumer Healthcare (NYSE:PBH) stock in their portfolio include Invesco Dynamic Pharmaceuticals ETF (PJP), Invesco S&P SmallCap Health Care ETF (PSCH), Schwab Ariel ESG ETF (SAEF), SPDR S&P Pharmaceuticals ETF (XPH), Global X Health & Wellness ETF (BFIT), ETC 6 Meridian Small Cap Equity ETF (SIXS), iShares U.S. Pharmaceuticals ETF (IHE) and Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL). What guidance has Prestige Consumer Healthcare issued on next quarter's earnings? Prestige Consumer Healthcare updated its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share (EPS) guidance of $4.27-$4.32 for the period, compared to the consensus earnings per share estimate of $4.18. The company issued revenue guidance of $1.14 billion-$1.14 billion, compared to the consensus revenue estimate of $1.12 billion. What is Ronald M. Lombardi's approval rating as Prestige Consumer Healthcare's CEO? 8 employees have rated Prestige Consumer Healthcare Chief Executive Officer Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among the company's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Prestige Consumer Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE), Wells Fargo & Company (WFC), International Business Machines (IBM), Micron Technology (MU) and Teva Pharmaceutical Industries (TEVA). What is Prestige Consumer Healthcare's stock symbol? Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH." Who are Prestige Consumer Healthcare's major shareholders? Prestige Consumer Healthcare's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (18.35%), Dimensional Fund Advisors LP (7.40%), Macquarie Group Ltd. (5.54%), State Street Corp (3.85%), FMR LLC (2.14%) and Geode Capital Management LLC (2.07%). Insiders that own company stock include Mary Beth Fritz and Ronald M Lombardi. View institutional ownership trends. How do I buy shares of Prestige Consumer Healthcare? Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Prestige Consumer Healthcare's stock price today? One share of PBH stock can currently be purchased for approximately $56.70. How much money does Prestige Consumer Healthcare make? Prestige Consumer Healthcare (NYSE:PBH) has a market capitalization of $2.82 billion and generates $1.13 billion in revenue each year. The company earns $-82,310,000.00 in net income (profit) each year or ($1.68) on an earnings per share basis. How many employees does Prestige Consumer Healthcare have? The company employs 505 workers across the globe. How can I contact Prestige Consumer Healthcare? Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The official website for the company is www.prestigebrands.com. The company can be reached via phone at (914) 524-6800, via email at irinquiries@prestigebrands.com, or via fax at 302-674-5266. This page (NYSE:PBH) was last updated on 6/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prestige Consumer Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.